Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anusol Ointment for Haemorrhoid Symptom Relief
NCT05157711Phase 3Completed
- Sponsor
- Church & Dwight
- Start
- Nov 2021
- Primary completion
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of hydrocortisone in Hemorrhoids (3 arms), sponsored by Church & Dwight. Primary endpoints: Subject reported severity of heamorrhoid symptoms at Day 14, Subject reported improvement of heamorrhoid symptoms at Day 14 and 5 more. Started Nov 2021; status: completed.
02
Drugs
hydrocortisone
03
Conditions
Hemorrhoids
Beyond the preview
Go deeper on NCT05157711.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05157711.